Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2002 Jan;48:104–110.

What patients want to know about their medications. Focus group study of patient and clinician perspectives.

Kalpana Nair 1, Lisa Dolovich 1, Alan Cassels 1, James McCormack 1, Mitch Levine 1, Jean Gray 1, Karen Mann 1, Sheri Burns 1
PMCID: PMC2213938  PMID: 11852597

Abstract

OBJECTIVE: To describe what patients want to know about their medications and how they currently access information. To describe how physicians and pharmacists respond to patients' information needs. To use patients', physicians', and pharmacists' feedback to develop evidence-based treatment information sheets. DESIGN: Qualitative study using focus groups and a grounded-theory approach. SETTING: Three regions of Canada (British Columbia, Nova Scotia, and Ontario). PARTICIPANTS: Eighty-eight patients, 27 physicians, and 35 pharmacists each took part in one of 19 focus groups. METHOD: Purposeful and convenience sampling was used. A trained facilitator used a semistructured interview guide to conduct the focus groups. Analysis was completed by at least two research-team members. MAIN FINDINGS: Patients wanted both general and specific information when considering medication treatments. They wanted basic information about the medical condition being treated and specific information about side effects, duration of treatment, and range of available treatment options. Physicians and pharmacists questioned the amount of side-effect and safety information patients wanted and thought that too much information might deter patients from taking their medications. Patients, physicians, and pharmacists supported the use of evidence-based treatment information sheets. CONCLUSION: Patients and clinicians each appear to have a different understanding of what and how much information patients should receive about medications. Feedback from patients can be used to develop patient-oriented treatment information.

Full Text

The Full Text of this article is available as a PDF (316.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buck M. L. Providing patients with written medication information. Ann Pharmacother. 1998 Sep;32(9):962–969. doi: 10.1345/aph.17455. [DOI] [PubMed] [Google Scholar]
  2. Connelly M. T., Ferrari N., Hagen N., Inui T. S. Patient-identified needs for hormone replacement therapy counseling: a qualitative study. Ann Intern Med. 1999 Aug 17;131(4):265–268. doi: 10.7326/0003-4819-131-4-199908170-00005. [DOI] [PubMed] [Google Scholar]
  3. Davis T. C., Michielutte R., Askov E. N., Williams M. V., Weiss B. D. Practical assessment of adult literacy in health care. Health Educ Behav. 1998 Oct;25(5):613–624. doi: 10.1177/109019819802500508. [DOI] [PubMed] [Google Scholar]
  4. Dowell J., Hudson H. A qualitative study of medication-taking behaviour in primary care. Fam Pract. 1997 Oct;14(5):369–375. doi: 10.1093/fampra/14.5.369. [DOI] [PubMed] [Google Scholar]
  5. Eaden J. A., Ward B., Smith H., Mayberry J. F. Are we telling patients enough? A pilot study to assess patient information needs in a gastroenterology outpatient department. Eur J Gastroenterol Hepatol. 1998 Jan;10(1):63–67. doi: 10.1097/00042737-199801000-00012. [DOI] [PubMed] [Google Scholar]
  6. Howland J. S., Baker M. G., Poe T. Does patient education cause side effects? A controlled trial. J Fam Pract. 1990 Jul;31(1):62–64. [PubMed] [Google Scholar]
  7. Kitzinger J. Qualitative research. Introducing focus groups. BMJ. 1995 Jul 29;311(7000):299–302. doi: 10.1136/bmj.311.7000.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lamb G. C., Green S. S., Heron J. Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med. 1994 Dec 12;154(23):2753–2756. doi: 10.1001/archinte.1994.00420230150018. [DOI] [PubMed] [Google Scholar]
  9. Morris L. A., Tabak E. R., Gondek K. Counseling patients about prescribed medication: 12-year trends. Med Care. 1997 Oct;35(10):996–1007. doi: 10.1097/00005650-199710000-00002. [DOI] [PubMed] [Google Scholar]
  10. Myers E. D., Calvert E. J. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on amitriptyline. Br J Psychiatry. 1973 Apr;122(569):461–464. doi: 10.1192/bjp.122.4.461. [DOI] [PubMed] [Google Scholar]
  11. Thomas L. G., Corwin E. J. The readability of printed education materials regarding hormone replacement therapy. J Am Acad Nurse Pract. 1998 Oct;10(10):447–452. doi: 10.1111/j.1745-7599.1998.tb00469.x. [DOI] [PubMed] [Google Scholar]
  12. Wilkes M. S., Bell R. A., Kravitz R. L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) 2000 Mar-Apr;19(2):110–128. doi: 10.1377/hlthaff.19.2.110. [DOI] [PubMed] [Google Scholar]
  13. Ziegler D. K., Mosier M. C., Buenaver M., Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001 Mar 12;161(5):706–713. doi: 10.1001/archinte.161.5.706. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES